Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
67,185.13 +1,405.12 (+2.14%) CMC Crypto 200
1,375.21 +1.36 (+0.10%)
Stoke Therapeutics, Inc. (STOK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:51AM EDT. Market open.
| Previous close | 14.03 |
| Open | 14.11 |
| Bid | 13.88 x 200 |
| Ask | 14.13 x 200 |
| Day's range | 13.73 - 14.18 |
| 52-week range | 3.35 - 16.40 |
| Volume | |
| Avg. volume | 1,361,706 |
| Market cap | 730.2M |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Stoke Therapeutics Inc (STOK) Reports Q1 2024 Financial Results: A Closer Look at Challenges ...
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments
- Simply Wall St.
Stoke Therapeutics First Quarter 2024 Earnings: Beats Expectations
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
- Zacks
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 5% and 26.61%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.